BioRestorative Therapies Inc.

BRTX | NASDAQ

Price Alert Chart Builder DCF Calculator

$2.71

+$0.02 (+0.74%)

At close: Sep 21, 2026, 4:00 PM ET

$2.69

-$0.02 (-0.74%)

Pre-market: Sep 22, 2026, 5:02 AM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

+0.74%

(1D)

Rating

Updated: Sep 9, 2026

Fundamentals Average

Market Sentiment Neutral

Moat None

Full Analysis

Key Statistics

Market Data

Market Cap $3.74M

1D Range

2.68 2.75

52W Range

2.55 34.60

Valuation (TTM)

PE -0.12

PB 1.24

EV/EBITDA -0.02

Valuation (NTM)

Forward PE N/A

Forward PEG 0.01

Price Target N/A

Cash Flow

FCF Yield -317.9%

SBC Adj. FCF Yield -360.8%

SBC Impact -13.5%

Margins

Gross Margin 92.1%

Operating Margin -3975.0%

FCF Margin -3324.6%

Growth (CAGR)

Revenue 3Y | 5Y 38.4% | 39.0%

Dil EPS 3Y | 5Y 2.0% | 68.3%

FCF 3Y | 5Y -28.6% | -22.1%

Returns

ROA -238.3%

ROE -423.8%

ROIC -464.9%

Financial Health

Net Cash

$3.56M

Current Ratio 2.35

Interest Coverage 0.00

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

BioRestorative Therapies, Inc., a life sciences company, focuses on the development of regenerative medicine products and therapies using cell and tissue protocols primarily involving adult stem cells...

Sector Healthcare

Industry Biotechnology

Employees 11

IPO Date Dec 4, 2012

Website www.biorestorative.com

Fiscal Year January - December

Full Company Profile

Latest News

No news articles available yet.

Earnings

Next Earnings

Sep 22, 2026

EPS Est

Pro

Rev Est

Pro

Earnings Details ➞